Don’t Push Mayo To The Side, Hikma Urges Top US Court

 
• By Aidan Fry

The US Supreme Court should insist that the Court of Appeals for the Federal Circuit respect the landmark Mayo ruling that renders pharmaceutical method-of-treatment patents liable to the same eligibility criteria as other patents, Hikma argues in a petition just filed.

Chips
The US Federal Circuit's ruling last year on iloperidone chips away at Supreme Court precedents on patent eligibility, Hikma argues • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin